Stockreport

BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns [Seeking Alpha]

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF Follow Summary BriaCell Therapeutics' lead candidate, Bria-IMT, shows promising trial results for metastatic breast cancer, potentially doubling overall survival an [Read more]